Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of drug compound and its preparation method and application

A drug compound and drug technology, applied in the medical field, can solve the problem of difficult release of functional EGCG, etc., and achieve the effect of improving the efficacy of small molecule drugs, good stability, and high drug loading

Active Publication Date: 2020-11-10
单玲玲
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the nanomicelle drug carrier formed by the self-assembly of small molecule drugs encapsulated by amphiphilic block copolymers still has amphiphilic block copolymers dispersed into macromolecules in vivo, and it is difficult to release functional EGCG. Achieving synergy between EGCG and small molecule anticancer drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of drug compound and its preparation method and application
  • A kind of drug compound and its preparation method and application
  • A kind of drug compound and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0076] Embodiment 1: the preparation method of drug-carrying system

[0077] see figure 1 , the preparation steps of the drug-loaded system are as follows:

[0078] 1. Use DMF (dimethylformamide) as the solvent of doxorubicin hydrochloride DOX-HCl, the concentration is 3mg / mL, add trifluoroethylamine dropwise, the molar ratio of doxorubicin hydrochloride and trifluoroethylamine is 1:10 , react overnight, remove hydrochloric acid, and prepare hydrophobic doxorubicin DMF solution (excess trifluoroethylamine will volatilize).

[0079] 2. Utilize the amino group of dopamine and the carboxyl group at both ends of PEG-COOH (molecular weight 0.5-200,000) to carry out amide reaction under the catalysis of EDC / NHS or DCC / NHS to generate PEG-dopamine, and further add the carboxyl group at the other end of PEG to PEG-dopamine / The amino group and the amino / carboxyl group of the fluorescent dye undergo amide reaction under the catalysis of EDC / NHS or DCC / NHS to prepare a fluorescent dy...

Embodiment 2

[0087] Example 2: Optimization and characterization of drug-loading system preparation

[0088] Using the method of Example 1, three different molar concentrations of ferric chloride 0.554mmol / L, 0.925mmol / L and 1.479mmol / L were used to prepare three kinds of drug-carrying systems, and named as DFEP-A, DFEP -B and DFEP-C, the results are as figure 2 As shown, the upper part is the photomicrograph, and the lower part is the diameter distribution.

[0089] From figure 2 It can be seen that the particle size increases with increasing concentration. The particle sizes of the three nano-drug loading systems are: DFEP-A: 77.4±13nm, DFEP-B: 126±24nm, DFEP-C: 296±19.7nm.

Embodiment 3

[0090] Example 3: Uptake of drug delivery system in tumor cells

[0091] Materials: Human glioma cells U87MG tumor cells were purchased from the Cell Bank of the Chinese Academy of Sciences.

[0092] DFEP-ANPs and DFEP-B NPs are from Example 2 of the present invention.

[0093] Test steps: put 2*10 5 U87MG cells were plated in a confocal 4-well plate at 37°C, 5% CO 2 , 90% humidity constant temperature incubator for overnight cultivation. Add 100 μL of 0.554mmol / L DFEP-A and 0.925mmol / L DFEP-B into 4-well plate U87MG cells respectively, incubate for 1, 4 and 8 hours, discard the culture medium, add 1mL PBS to wash, repeat 2-3 Once, fixed with 4% formaldehyde fixative solution for 20min, dripped DAPI dye solution to stain cell nuclei for 5min, covered with a cover glass, and observed under a laser confocal scanning microscope with a magnification of 200 times. It can be clearly seen that the DFEP-A and The green fluorescence and red fluorescence brightness of tumor cells U8...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention discloses a pharmaceutical compound. The pharmaceutical compound is prepared from the following components: a metal ions with coordination capability, a small molecule drug, tea polyphenol and peripheral molecules, wherein the peripheral molecules comprises soluble framework high molecules and polyphenol, or the soluble framework high molecules, the polyphenol and fluorescent molecules. The invention further discloses a preparation method of the pharmaceutical compound and application or usage to drug in-vivo imaging and tracking, preparation of tumor diagnostic preparations or preparation of accurate treatment preparations. The pharmaceutical compound can be used for passively targeting tumor cells and can realize the cooperative effect of treating tumors.

Description

technical field [0001] The invention belongs to the medical field, and relates to a drug-carrying system and its preparation method and application, in particular to the preparation of a self-assembled epigallocatechin gallate (EGCG) nanoparticle drug-carrying system and the application of synergistic drug use. Background technique [0002] Epigallocatechin gallate (EGCG) belongs to the catechol family and is mainly derived from tea polyphenols in green tea. EGCG is a typical polyphenolic compound. Because it has active gallic catechin and gallic catechin groups in its structure, EGCG has strong antioxidant properties and can be used as a strong antioxidant to scavenge free radicals in the body. Recent studies have found that EGCG can inhibit the CBR1 protein to block the conversion of doxorubicin (DOX) into doxorubicin alcohol (DOXOL), thereby improving the anticancer efficacy of DOX. At the same time, EGCG is known as a broad-spectrum disease intervention supplement for A...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/51A61K47/02A61K47/10A61K47/54A61K31/704A61K31/353A61P35/00A61K49/00
CPCA61K9/5115A61K9/5123A61K9/5146A61K9/5192A61K31/353A61K31/704A61K47/54A61K49/0021A61P35/00A61K2300/00
Inventor 单玲玲代云路陈小元
Owner 单玲玲